MillennialEYE named Kathryn M. Hatch, MD, an “Outstanding female leader in ophthalmology” in their January/February 2017, and published a profile about her career and work. MillennialEYE is an all-digital publication and online community for the future leaders in ophthalmology. The full story can be found on their website.
Mass. Eye and Earwas included in Boston Magazine's "Boston Hospitals with Niche Specialties," as the only hospital with a 24/7 eye emergency room in New England. See the full article in Boston Magazine.
ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, has announced that Joan W. Miller, MD, Chair of the Department of Ophthalmology, Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, is one of five of the world’s premier retinal disease thought leaders who will serve on its newly formed scientific advisory board (SAB). The goal of the SAB is to help guide development of novel Read more about ONL Therapeutics Announces Formation of Scientific Advisory Board
Boston, MA Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell Reports, could potentially be used to design gene therapies that are not only safer and more potent than therapies currently available, but may also help a greater number of patients.